Suppr超能文献

自身免疫易感性基因 FcRL3 在人调节性 T 细胞上的表达与功能障碍和程序性细胞死亡-1 高水平相关。

Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.

机构信息

Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, CA 94110, USA.

出版信息

J Immunol. 2010 Apr 1;184(7):3639-47. doi: 10.4049/jimmunol.0903943. Epub 2010 Feb 26.

Abstract

CD4(+)FoxP3(+) regulatory T cells (T(reg)) play a critical role in maintaining self-tolerance and inhibiting autoimmune disease. Despite being a major focus of modern immunological investigation, many aspects of T(reg) biology remain unknown. In a screen for novel candidate genes involved in human T(reg) function, we detected the expression of an autoimmune susceptibility gene, FcRL3, in T(reg) but not in conventional CD4(+) T cells. FcRL3 is an orphan receptor of unknown function with structural homology to classical Fc receptors. Numerous genetic studies have demonstrated a link between a single nucleotide polymorphism in the FCRL3 promoter and both overexpression of FcRL3 and autoimmune diseases such as rheumatoid arthritis. Given the critical role of T(reg) in suppressing autoimmunity, we sought to ascertain how expression of FcRL3 relates to the phenotype, differentiation, and function of T(reg). We show in this study that FcRL3 is expressed on a population of thymically derived T(reg) that exhibits a memory phenotype and high levels of programmed cell death-1. Purified FcRL3(+) T(reg) are less responsive to antigenic stimulation in the presence of IL-2 than their FcRL3(-) counterparts, despite intact proximal and distal IL-2 signaling as determined by phosphorylation of Stat-5 and upregulation of Bcl2. In vitro suppression assays demonstrated that FcRL3(+) T(reg) have reduced capacity to suppress the proliferation of effector T cells. These data suggest that FcRL3 expression is associated with T(reg) dysfunction that may, in turn, contribute to the loss of self-tolerance and the development of autoimmunity.

摘要

CD4(+)FoxP3(+) 调节性 T 细胞(T(reg))在维持自身耐受和抑制自身免疫性疾病方面发挥着关键作用。尽管 T(reg)生物学的许多方面仍然未知,但它是现代免疫学研究的主要焦点。在筛选涉及人类 T(reg)功能的新候选基因的过程中,我们在 T(reg)中检测到了自身免疫易感性基因 FcRL3 的表达,但在常规 CD4(+)T 细胞中未检测到。FcRL3 是一种功能未知的孤儿受体,与经典 Fc 受体具有结构同源性。许多遗传研究表明,FcRL3 启动子中的单核苷酸多态性与 FcRL3 的过度表达以及类风湿关节炎等自身免疫性疾病之间存在关联。鉴于 T(reg)在抑制自身免疫中的关键作用,我们试图确定 FcRL3 的表达与 T(reg)的表型、分化和功能有何关系。在这项研究中,我们表明 FcRL3 在表达一种记忆表型和高水平程序性细胞死亡-1 的胸腺衍生 T(reg)群体上表达。在存在 IL-2 的情况下,与 FcRL3(-)相比,FcRL3(+)T(reg)对抗原刺激的反应性较低,尽管通过磷酸化 Stat-5 和上调 Bcl2 来确定,其近端和远端的 IL-2 信号转导仍然完整。体外抑制试验表明,FcRL3(+)T(reg)抑制效应 T 细胞增殖的能力降低。这些数据表明,FcRL3 的表达与 T(reg)功能障碍有关,而 T(reg)功能障碍反过来又可能导致自身耐受的丧失和自身免疫的发展。

相似文献

4
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.人类红斑狼疮中的CD4(+)CD25(+)调节性T细胞
Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5.
5
Regulatory T cells in human autoimmune thyroid disease.人类自身免疫性甲状腺疾病中的调节性T细胞。
J Clin Endocrinol Metab. 2006 Sep;91(9):3639-46. doi: 10.1210/jc.2005-2337. Epub 2006 Jun 27.
6
FOXP3+ regulatory T cells in the human immune system.FOXP3+ 调节性 T 细胞在人类免疫系统中的作用。
Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18.

引用本文的文献

8
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?CD4 T 细胞耗竭:它是否存在,以及在癌症中扮演什么角色?
Clin Cancer Res. 2021 Nov 1;27(21):5742-5752. doi: 10.1158/1078-0432.CCR-21-0206. Epub 2021 Jun 14.
9
Roles for the FCRL6 Immunoreceptor in Tumor Immunology.FCRL6 免疫受体在肿瘤免疫学中的作用。
Front Immunol. 2020 Oct 14;11:575175. doi: 10.3389/fimmu.2020.575175. eCollection 2020.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验